Brief: Theranexus End-June Available Funds At Eur 11.6 Mln
12/07/2022 17:21
July 12 (Reuters) - Theranexus SA ALTHX.PA :
* TOTAL AVAILABLE FUNDS ON 30 JUNE 2022 STOOD AT EUR 11.6
MLN,
COMPARED WITH EUR 12.5 MLN ON 31 DECEMBER 2021
Source text for Eikon: ID:nACT75499
Further company coverage: ALTHX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Thx Pharma SA
See all newsBrief: Theranexus And BBDF Announce Final And Positive Safety And Efficacy Data In The Phase I/II Trial Testing Batten-1
Brief: Theranexus End-Dec Total Available Funds Stood At EUR 4.9 Mln
Brief: Theranexus Declares Encouraging Prelim Results For Batten Disease Drug
Brief: Theranexus And BBDF Granted Positive Opinion By EMA For Design Of Batten-1 Phase III Trial
Brief: Theranexus And BBDF Win FDA Approval On Endpoints For Phase III Trial To Evaluate Batten-1 In CLN3 Batten Disease